
LINK . SPRINGER . COM {
}
Title:
Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance | Breast Cancer Research
Description:
Background The effects of neoadjuvant chemotherapy on immune markers remain largely unknown. The specific aim of this study was to assess stromal tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) protein expression in a cohort of breast cancer patients treated with neoadjuvant chemotherapy. Methods Using quantitative immunofluorescence, we investigated stromal TILs and PD-L1 protein expression in pre-treatment and residual breast cancer tissue from a Yale Cancer Center patient cohort of 58 patients diagnosed with breast cancer from 2003 to 2009 and treated with neoadjuvant chemotherapy. We compared the TIL count and PD-L1 status in paired pre-treatment and residual cancer tissues and correlated changes and baseline levels with survival. Results Of the 58 patients, 46 (79.3%) had hormone-positive and 34 (58.6%) had node-positive breast cancer. Eighty-six percent of residual cancer tissues had TIL infiltration and 17% had PD-L1 expression. There was a trend for higher TIL counts in postchemotherapy compared to prechemotherapy samples (p = 0.09). Increase in TIL count was associated with longer 5-year recurrence-free survival (p = 0.02, HR = 3.9, 95% CI = 1.179–15.39). PD-L1 expression (both stromal and tumor cells) was significantly lower in post-treatment samples (p = 0.001). Change in PD-L1 expression after therapy or TILs and PD-L1 expression in the posttreatment samples did not correlate with survival. Conclusions Increase in stromal TILs in residual cancer compared to pretreatment tissue is associated with improved recurrence-free survival. Despite a trend for increasing TIL counts, PD-L1 expression decreased in residual disease compared to pretreatment samples.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Health & Fitness
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't tell how the site generates income.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.
Keywords {🔍}
cancer, pdl, breast, expression, til, article, neoadjuvant, tumor, chemotherapy, residual, pubmed, tils, google, scholar, cases, cas, lymphocytes, stromal, treatment, data, baseline, survival, immune, study, patients, response, clin, analysis, tumorinfiltrating, pretreatment, disease, count, specimens, change, rimm, postneoadjuvant, qif, tissue, counts, oncol, cell, additional, res, compared, status, studies, scores, research, tissues, cells,
Topics {✒️}
jason brown & david pd-1/pd-l1-based treatments programmed death ligand-1 programmed death-ligand 1 subtype-specific metagene-based prediction bristol-myers squibb activate anti-tumor immunity pre-treatment pd-l1 assessment triple-negative breast cancer node-positive breast cancer full size image tumor-infiltrating foxp3+ regulatory neoadjuvant her2-directed therapies promote pd-l1-mediated reduced tumor-infiltrating lymphocytes early-stage breast cancer incorporating multi-institution cohorts article download pdf high-risk breast cancer pd-l1 expression decreased quantify pd-l1 expression pd-l1 expression correlates jason brown immune cell pd-l1 displays low pd-l1 adaptive resistance mechanism combined pd-axis blockade pd-l1-expressing cells post-neoadjuvant resection specimens showing pd-l1 expression small-cell lung cancer pd-l1 protein expression high pd-l1 expression pd-l1 multiplexed assay multiple immune-parameter modulation improved recurrence-free survival year recurrence-free survival low pd-l1 expression pd-l1 sp142 antibody dab-based chromogen visualization iii breast cancer pd-l1 expression prior pd-l1 protein levels stromal/immune cell scoring tumor-infiltrating lymphocytes analysis tumor pd-l1 levels ligand pd-l1 immune-related effect national cancer database post-neoadjuvant treatment based
Schema {🗺️}
WebPage:
mainEntity:
headline:Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
description:The effects of neoadjuvant chemotherapy on immune markers remain largely unknown. The specific aim of this study was to assess stromal tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) protein expression in a cohort of breast cancer patients treated with neoadjuvant chemotherapy. Using quantitative immunofluorescence, we investigated stromal TILs and PD-L1 protein expression in pre-treatment and residual breast cancer tissue from a Yale Cancer Center patient cohort of 58 patients diagnosed with breast cancer from 2003 to 2009 and treated with neoadjuvant chemotherapy. We compared the TIL count and PD-L1 status in paired pre-treatment and residual cancer tissues and correlated changes and baseline levels with survival. Of the 58 patients, 46 (79.3%) had hormone-positive and 34 (58.6%) had node-positive breast cancer. Eighty-six percent of residual cancer tissues had TIL infiltration and 17% had PD-L1 expression. There was a trend for higher TIL counts in postchemotherapy compared to prechemotherapy samples (p = 0.09). Increase in TIL count was associated with longer 5-year recurrence-free survival (p = 0.02, HR = 3.9, 95% CI = 1.179–15.39). PD-L1 expression (both stromal and tumor cells) was significantly lower in post-treatment samples (p = 0.001). Change in PD-L1 expression after therapy or TILs and PD-L1 expression in the posttreatment samples did not correlate with survival. Increase in stromal TILs in residual cancer compared to pretreatment tissue is associated with improved recurrence-free survival. Despite a trend for increasing TIL counts, PD-L1 expression decreased in residual disease compared to pretreatment samples.
datePublished:2017-08-07T00:00:00Z
dateModified:2017-09-25T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13058-017-0884-8
keywords:
Tumor infiltrating lymphocytes
Programmed death ligand 1
Neoadjuvant treatment
Breast cancer
Cancer Research
Oncology
Surgical Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_Fig3_HTML.gif
isPartOf:
name:Breast Cancer Research
issn:
1465-542X
volumeNumber:19
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Vasiliki Pelekanou
url:http://orcid.org/0000-0002-8431-1927
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Daniel E. Carvajal-Hausdorf
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Mehmet Altan
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Brad Wasserman
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Cristobal Carvajal-Hausdorf
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Hallie Wimberly
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Jason Brown
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Donald Lannin
affiliation:
name:Yale University School of Medicine
address:
name:Department of Surgery, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Lajos Pusztai
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:David L. Rimm
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
description:The effects of neoadjuvant chemotherapy on immune markers remain largely unknown. The specific aim of this study was to assess stromal tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) protein expression in a cohort of breast cancer patients treated with neoadjuvant chemotherapy. Using quantitative immunofluorescence, we investigated stromal TILs and PD-L1 protein expression in pre-treatment and residual breast cancer tissue from a Yale Cancer Center patient cohort of 58 patients diagnosed with breast cancer from 2003 to 2009 and treated with neoadjuvant chemotherapy. We compared the TIL count and PD-L1 status in paired pre-treatment and residual cancer tissues and correlated changes and baseline levels with survival. Of the 58 patients, 46 (79.3%) had hormone-positive and 34 (58.6%) had node-positive breast cancer. Eighty-six percent of residual cancer tissues had TIL infiltration and 17% had PD-L1 expression. There was a trend for higher TIL counts in postchemotherapy compared to prechemotherapy samples (p = 0.09). Increase in TIL count was associated with longer 5-year recurrence-free survival (p = 0.02, HR = 3.9, 95% CI = 1.179–15.39). PD-L1 expression (both stromal and tumor cells) was significantly lower in post-treatment samples (p = 0.001). Change in PD-L1 expression after therapy or TILs and PD-L1 expression in the posttreatment samples did not correlate with survival. Increase in stromal TILs in residual cancer compared to pretreatment tissue is associated with improved recurrence-free survival. Despite a trend for increasing TIL counts, PD-L1 expression decreased in residual disease compared to pretreatment samples.
datePublished:2017-08-07T00:00:00Z
dateModified:2017-09-25T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13058-017-0884-8
keywords:
Tumor infiltrating lymphocytes
Programmed death ligand 1
Neoadjuvant treatment
Breast cancer
Cancer Research
Oncology
Surgical Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_Fig3_HTML.gif
isPartOf:
name:Breast Cancer Research
issn:
1465-542X
volumeNumber:19
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Vasiliki Pelekanou
url:http://orcid.org/0000-0002-8431-1927
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Daniel E. Carvajal-Hausdorf
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Mehmet Altan
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Brad Wasserman
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Cristobal Carvajal-Hausdorf
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Hallie Wimberly
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Jason Brown
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Donald Lannin
affiliation:
name:Yale University School of Medicine
address:
name:Department of Surgery, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Lajos Pusztai
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:David L. Rimm
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Breast Cancer Research
issn:
1465-542X
volumeNumber:19
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Surgery, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Vasiliki Pelekanou
url:http://orcid.org/0000-0002-8431-1927
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Daniel E. Carvajal-Hausdorf
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Mehmet Altan
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Brad Wasserman
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Cristobal Carvajal-Hausdorf
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Hallie Wimberly
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Jason Brown
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Donald Lannin
affiliation:
name:Yale University School of Medicine
address:
name:Department of Surgery, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Lajos Pusztai
affiliation:
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:David L. Rimm
affiliation:
name:Yale University School of Medicine
address:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Yale University School of Medicine
address:
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
name:Department of Surgery, Yale University School of Medicine, New Haven, USA
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
name:Department of Pathology, Yale University School of Medicine, New Haven, USA
name:Department of Medical Oncology, Yale University School of Medicine, New Haven, USA
External Links {🔗}(165)
- See how much https://www.springernature.com/gp/authors makes per month
- How much does https://link.springernature.com/home/ pull in monthly?
- What's the financial outcome of https://order.springer.com/public/cart?
- How much profit does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research generate?
- How much profit does https://breast-cancer-research.biomedcentral.com/about generate?
- What's the financial gain of https://submission.nature.com/new-submission/13058/3?
- How much money does https://orcid.org/0000-0002-8431-1927 make?
- How much does https://doi.org/10.1200%2FJCO.2007.14.4147 earn?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18250347
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Response%20to%20neoadjuvant%20therapy%20and%20long-term%20survival%20in%20patients%20with%20triple-negative%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.14.4147&volume=26&issue=8&pages=1275-81&publication_year=2008&author=Liedtke%2CC&author=Mazouni%2CC&author=Hess%2CKR&author=Andre%2CF&author=Tordai%2CA&author=Mejia%2CJA&author=Symmans%2CWF&author=Gonzalez-Angulo%2CAM&author=Hennessy%2CB&author=Green%2CM each month?
- What's the monthly income of https://doi.org/10.1200%2FJCO.2007.10.6823?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17785706?
- How much does http://scholar.google.com/scholar_lookup?&title=Measurement%20of%20residual%20breast%20cancer%20burden%20to%20predict%20survival%20after%20neoadjuvant%20chemotherapy&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.10.6823&volume=25&issue=28&pages=4414-22&publication_year=2007&author=Symmans%2CWF&author=Peintinger%2CF&author=Hatzis%2CC&author=Rajan%2CR&author=Kuerer%2CH&author=Valero%2CV&author=Assad%2CL&author=Poniecka%2CA&author=Hennessy%2CB&author=Green%2CM rake in every month?
- See how much https://doi.org/10.1016%2Fj.jamcollsurg.2015.02.011 makes per month
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25868410 earns monthly
- Earnings of http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20chemotherapy%20for%20breast%20cancer%20increases%20the%20rate%20of%20breast%20conservation%3A%20results%20from%20the%20National%20Cancer%20Database&journal=J%20Am%20Coll%20Surg&doi=10.1016%2Fj.jamcollsurg.2015.02.011&volume=220&issue=6&pages=1063-9&publication_year=2015&author=Killelea%2CBK&author=Yang%2CVQ&author=Mougalian%2CS&author=Horowitz%2CNR&author=Pusztai%2CL&author=Chagpar%2CAB&author=Lannin%2CDR
- How much does https://doi.org/10.1002%2Fcncr.29348 net monthly?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25902916?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Use%20of%20neoadjuvant%20chemotherapy%20for%20patients%20with%20stage%20I%20to%20III%20breast%20cancer%20in%20the%20United%20States&journal=Cancer&doi=10.1002%2Fcncr.29348&volume=121&issue=15&pages=2544-52&publication_year=2015&author=Mougalian%2CSS&author=Soulos%2CPR&author=Killelea%2CBK&author=Lannin%2CDR&author=Abu-Khalaf%2CMM&author=DiGiovanna%2CMP&author=Sanft%2CTB&author=Pusztai%2CL&author=Gross%2CCP&author=Chagpar%2CAB
- What is the monthly revenue of https://doi.org/10.1158%2F1078-0432.CCR-11-2701?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23258741 net monthly?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Molecular%20pathways%3A%20involvement%20of%20immune%20pathways%20in%20the%20therapeutic%20response%20and%20outcome%20in%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-11-2701&volume=19&issue=1&pages=28-33&publication_year=2013&author=Andre%2CF&author=Dieci%2CMV&author=Dubsky%2CP&author=Sotiriou%2CC&author=Curigliano%2CG&author=Denkert%2CC&author=Loi%2CS?
- What's the financial outcome of https://doi.org/10.1200%2FJCO.2009.27.2419?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20805453's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Molecular%20anatomy%20of%20breast%20cancer%20stroma%20and%20its%20prognostic%20value%20in%20estrogen%20receptor-positive%20and%20-negative%20cancers&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.27.2419&volume=28&issue=28&pages=4316-23&publication_year=2010&author=Bianchini%2CG&author=Qi%2CY&author=Alvarez%2CRH&author=Iwamoto%2CT&author=Coutant%2CC&author=Ibrahim%2CNK&author=Valero%2CV&author=Cristofanilli%2CM&author=Green%2CMC&author=Radvanyi%2CL make?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-07-4491 rake in every month?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18413832
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Pathologic%20complete%20response%20to%20neoadjuvant%20chemotherapy%20of%20breast%20carcinoma%20is%20associated%20with%20the%20disappearance%20of%20tumor-infiltrating%20foxp3%2B%20regulatory%20T%20cells&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-4491&volume=14&issue=8&pages=2413-20&publication_year=2008&author=Ladoire%2CS&author=Arnould%2CL&author=Apetoh%2CL&author=Coudert%2CB&author=Martin%2CF&author=Chauffert%2CB&author=Fumoleau%2CP&author=Ghiringhelli%2CF?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11595690 make?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Development%20of%20tumor-infiltrating%20lymphocytes%20in%20breast%20cancer%20after%20neoadjuvant%20paclitaxel%20chemotherapy&journal=Clin%20Cancer%20Res&volume=7&issue=10&pages=3025-30&publication_year=2001&author=Demaria%2CS&author=Volm%2CMD&author=Shapiro%2CRL&author=Yee%2CHT&author=Oratz%2CR&author=Formenti%2CSC&author=Muggia%2CF&author=Symmans%2CWF?
- How much profit does https://doi.org/10.1093%2Fannonc%2Fmdt556 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24401929 income
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933248's financial summary
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20tumor-infiltrating%20lymphocytes%20on%20residual%20disease%20after%20primary%20chemotherapy%20for%20triple-negative%20breast%20cancer%3A%20a%20retrospective%20multicenter%20study&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdt556&volume=25&issue=3&pages=611-8&publication_year=2014&author=Dieci%2CMV&author=Criscitiello%2CC&author=Goubar%2CA&author=Viale%2CG&author=Conte%2CP&author=Guarneri%2CV&author=Ficarra%2CG&author=Mathieu%2CMC&author=Delaloge%2CS&author=Curigliano%2CG?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25432519?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303200 pull in monthly?
- Get to know http://scholar.google.com/scholar_lookup?&title=Tumor-infiltrating%20immune%20cell%20profiles%20and%20their%20change%20after%20neoadjuvant%20chemotherapy%20predict%20response%20and%20prognosis%20of%20breast%20cancer&journal=Breast%20Cancer%20Res&doi=10.1186%2Fs13058-014-0488-5&volume=16&issue=6&publication_year=2014&author=Garcia-Martinez%2CE&author=Gil%2CGL&author=Benito%2CAC&author=Gonzalez-Billalabeitia%2CE&author=Conesa%2CMA&author=Garcia%20Garcia%2CT&author=Garcia-Garre%2CE&author=Vicente%2CV&author=Ayala%20dela%20Pena%2CF's earnings
- What's the income generated by https://doi.org/10.1158%2F1078-0432.CCR-11-2762 each month?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22235097?
- What's http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288822's gross income?
- How much does http://scholar.google.com/scholar_lookup?&title=Gene%20expression%2C%20molecular%20class%20changes%2C%20and%20pathway%20analysis%20after%20neoadjuvant%20systemic%20therapy%20for%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-11-2762&volume=18&issue=4&pages=1109-19&publication_year=2012&author=Gonzalez-Angulo%2CAM&author=Iwamoto%2CT&author=Liu%2CS&author=Chen%2CH&author=Do%2CKA&author=Hortobagyi%2CGN&author=Mills%2CGB&author=Meric-Bernstam%2CF&author=Symmans%2CWF&author=Pusztai%2CL earn?
- https://doi.org/10.1200%2FJCO.2009.23.7370 income
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19917869's total income per month
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20lymphocytes%20as%20an%20independent%20predictor%20of%20response%20to%20neoadjuvant%20chemotherapy%20in%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.23.7370&volume=28&issue=1&pages=105-13&publication_year=2010&author=Denkert%2CC&author=Loibl%2CS&author=Noske%2CA&author=Roller%2CM&author=Muller%2CBM&author=Komor%2CM&author=Budczies%2CJ&author=Darb-Esfahani%2CS&author=Kronenwett%2CR&author=Hanusch%2CC
- Revenue of https://doi.org/10.1200%2FJCO.2014.58.1967
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25534375?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Tumor-infiltrating%20lymphocytes%20and%20response%20to%20neoadjuvant%20chemotherapy%20with%20or%20without%20carboplatin%20in%20human%20epidermal%20growth%20factor%20receptor%202-positive%20and%20triple-negative%20primary%20breast%20cancers&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2014.58.1967&volume=33&issue=9&pages=983-91&publication_year=2015&author=Denkert%2CC&author=Minckwitz%2CG&author=Brase%2CJC&author=Sinn%2CBV&author=Gade%2CS&author=Kronenwett%2CR&author=Pfitzner%2CBM&author=Salat%2CC&author=Loi%2CS&author=Schmitt%2CWD?
- How much profit does https://doi.org/10.1158%2F1078-0432.CCR-13-2702 make?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24647569 generate?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=In%20situ%20tumor%20PD-L1%20mRNA%20expression%20is%20associated%20with%20increased%20TILs%20and%20better%20outcome%20in%20breast%20carcinomas&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-13-2702&volume=20&issue=10&pages=2773-82&publication_year=2014&author=Schalper%2CKA&author=Velcheti%2CV&author=Carvajal%2CD&author=Wimberly%2CH&author=Brown%2CJ&author=Pusztai%2CL&author=Rimm%2CDL?
- What's the income generated by https://doi.org/10.1158%2F1078-0432.CCR-14-1622 each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25255793 rake in every month?
- What's http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252785's gross income?
- See how much http://scholar.google.com/scholar_lookup?&title=Multiplexed%20quantitative%20analysis%20of%20CD3%2C%20CD8%2C%20and%20CD20%20predicts%20response%20to%20neoadjuvant%20chemotherapy%20in%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-1622&volume=20&issue=23&pages=5995-6005&publication_year=2014&author=Brown%2CJR&author=Wimberly%2CH&author=Lannin%2CDR&author=Nixon%2CC&author=Rimm%2CDL&author=Bossuyt%2CV makes per month
- Revenue of https://doi.org/10.1038%2Flabinvest.2013.128
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24189270?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Quantitative%20assessment%20Ki-67%20score%20for%20prediction%20of%20response%20to%20neoadjuvant%20chemotherapy%20in%20breast%20cancer&journal=Lab%20Invest&doi=10.1038%2Flabinvest.2013.128&volume=94&issue=1&pages=98-106&publication_year=2014&author=Brown%2CJR&author=DiGiovanna%2CMP&author=Killelea%2CB&author=Lannin%2CDR&author=Rimm%2CDL bring in?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12091876's financial summary
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20B7-H1%20promotes%20T-cell%20apoptosis%3A%20a%20potential%20mechanism%20of%20immune%20evasion&journal=Nat%20Med&volume=8&issue=8&pages=793-800&publication_year=2002&author=Dong%2CH&author=Strome%2CSE&author=Salomao%2CDR&author=Tamura%2CH&author=Hirano%2CF&author=Flies%2CDB&author=Roche%2CPC&author=Lu%2CJ&author=Zhu%2CG&author=Tamada%2CK?
- See how much https://doi.org/10.1001%2Fjamaoncol.2015.3638 makes per month
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26562159 generate?
- What's the income generated by http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941982 each month?
- http://scholar.google.com/scholar_lookup?&title=Quantitative%20Assessment%20of%20the%20Heterogeneity%20of%20PD-L1%20Expression%20in%20Non-Small-Cell%20Lung%20Cancer&journal=JAMA%20Oncol&doi=10.1001%2Fjamaoncol.2015.3638&volume=2&issue=1&pages=46-54&publication_year=2016&author=McLaughlin%2CJ&author=Han%2CG&author=Schalper%2CKA&author=Carvajal-Hausdorf%2CD&author=Pelekanou%2CV&author=Rehman%2CJ&author=Velcheti%2CV&author=Herbst%2CR&author=LoRusso%2CP&author=Rimm%2CDL's total income per month
- How much revenue does https://doi.org/10.1158%2F1078-0432.CCR-14-3073 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25788491 gross monthly?
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490112?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20PD-L1%20Expression%20and%20Associated%20T-cell%20Infiltrates%20in%20Metastatic%20Melanoma%20Samples%20from%20Variable%20Anatomic%20Sites&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-3073&volume=21&issue=13&pages=3052-60&publication_year=2015&author=Kluger%2CHM&author=Zito%2CCR&author=Barr%2CML&author=Baine%2CMK&author=Chiang%2CVL&author=Sznol%2CM&author=Rimm%2CDL&author=Chen%2CL&author=Jilaveanu%2CLB?
- Revenue of https://doi.org/10.1158%2F2326-6066.CIR-14-0133
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25527356 generate monthly?
- http://scholar.google.com/scholar_lookup?&title=PD-L1%20Expression%20Correlates%20with%20Tumor-Infiltrating%20Lymphocytes%20and%20Response%20to%20Neoadjuvant%20Chemotherapy%20in%20Breast%20Cancer&journal=Cancer%20Immunol%20Res&doi=10.1158%2F2326-6066.CIR-14-0133&volume=3&issue=4&pages=326-32&publication_year=2015&author=Wimberly%2CH&author=Brown%2CJR&author=Schalper%2CK&author=Haack%2CH&author=Silver%2CMR&author=Nixon%2CC&author=Bossuyt%2CV&author=Pusztai%2CL&author=Lannin%2CDR&author=Rimm%2CDL's total income per month
- https://doi.org/10.1126%2Fscitranslmed.3003689's financial summary
- Profit of http://scholar.google.com/scholar_lookup?&title=Colocalization%20of%20inflammatory%20response%20with%20B7-h1%20expression%20in%20human%20melanocytic%20lesions%20supports%20an%20adaptive%20resistance%20mechanism%20of%20immune%20escape&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.3003689&volume=4&issue=127&publication_year=2012&author=Taube%2CJM&author=Anders%2CRA&author=Young%2CGD&author=Xu%2CH&author=Sharma%2CR&author=McMiller%2CTL&author=Chen%2CS&author=Klein%2CAP&author=Pardoll%2CDM&author=Topalian%2CSL
- How profitable is https://doi.org/10.1158%2F1078-0432.CCR-15-1543?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26408403 earns monthly
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20PD-L1%20expression%20and%20associated%20tumor-infiltrating%20lymphocytes%20in%20laryngeal%20squamous%20cell%20carcinoma&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-15-1543&volume=22&issue=3&pages=704-13&publication_year=2016&author=Vassilakopoulou%2CM&author=Avgeris%2CM&author=Velcheti%2CV&author=Kotoula%2CV&author=Rampias%2CT&author=Chatzopoulos%2CK&author=Perisanidis%2CC&author=Kontos%2CCK&author=Giotakis%2CAI&author=Scorilas%2CA?
- Monthly income for https://doi.org/10.1016%2Fj.humpath.2015.09.003
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26527522 generate?
- Income figures for http://scholar.google.com/scholar_lookup?&title=PD-L1%20%28B7-H1%29%20expression%20and%20the%20immune%20tumor%20microenvironment%20in%20primary%20and%20metastatic%20breast%20carcinomas&journal=Hum%20Pathol&doi=10.1016%2Fj.humpath.2015.09.003&volume=47&issue=1&pages=52-63&publication_year=2016&author=Cimino-Mathews%2CA&author=Thompson%2CE&author=Taube%2CJM&author=Ye%2CX&author=Lu%2CY&author=Meeker%2CA&author=Xu%2CH&author=Sharma%2CR&author=Lecksell%2CK&author=Cornish%2CTC
- https://doi.org/10.1016%2Fj.coi.2011.12.009 income
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22236695 making per month?
- Earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319479
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20PD-1%2FB7-H1%28PD-L1%29%20pathway%20to%20activate%20anti-tumor%20immunity&journal=Curr%20Opin%20Immunol&doi=10.1016%2Fj.coi.2011.12.009&volume=24&issue=2&pages=207-12&publication_year=2012&author=Topalian%2CSL&author=Drake%2CCG&author=Pardoll%2CDM?
- What's https://doi.org/10.1200%2FJCO.2015.64.8931's gross income?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27138582 produce monthly?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20in%20patients%20with%20advanced%20triple-negative%20breast%20cancer%3A%20phase%20Ib%20KEYNOTE-012%20study&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2015.64.8931&volume=34&issue=21&pages=2460-7&publication_year=2016&author=Nanda%2CR&author=Chow%2CLQ&author=Dees%2CEC&author=Berger%2CR&author=Gupta%2CS&author=Geva%2CR&author=Pusztai%2CL&author=Pathiraja%2CK&author=Aktan%2CG&author=Cheng%2CJD
- What's the income of https://doi.org/10.1093%2Fannonc%2Fmdu450?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25214542 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=The%20evaluation%20of%20tumor-infiltrating%20lymphocytes%20%28TILs%29%20in%20breast%20cancer%3A%20recommendations%20by%20an%20International%20TILs%20Working%20Group%202014&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdu450&volume=26&issue=2&pages=259-71&publication_year=2015&author=Salgado%2CR&author=Denkert%2CC&author=Demaria%2CS&author=Sirtaine%2CN&author=Klauschen%2CF&author=Pruneri%2CG&author=Wienert%2CS&author=Eynden%2CG&author=Baehner%2CFL&author=Penault-Llorca%2CF generate monthly?
- How much does https://doi.org/10.1200%2FJCO.2011.41.0902 make?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23341518
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Prognostic%20and%20predictive%20value%20of%20tumor-infiltrating%20lymphocytes%20in%20a%20phase%20III%20randomized%20adjuvant%20breast%20cancer%20trial%20in%20node-positive%20breast%20cancer%20comparing%20the%20addition%20of%20docetaxel%20to%20doxorubicin%20with%20doxorubicin-based%20chemotherapy%3A%20BIG%2002-98&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2011.41.0902&volume=31&issue=7&pages=860-7&publication_year=2013&author=Loi%2CS&author=Sirtaine%2CN&author=Piette%2CF&author=Salgado%2CR&author=Viale%2CG&author=Eenoo%2CF&author=Rouas%2CG&author=Francis%2CP&author=Crown%2CJP&author=Hitre%2CE
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27393622 bring in?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963434?
- How profitable is http://scholar.google.com/scholar_lookup?&title=SWOG%20S0800%20%28NCI%20CDR0000636131%29%3A%20addition%20of%20bevacizumab%20to%20neoadjuvant%20nab-paclitaxel%20with%20dose-dense%20doxorubicin%20and%20cyclophosphamide%20improves%20pathologic%20complete%20response%20%28pCR%29%20rates%20in%20inflammatory%20or%20locally%20advanced%20breast%20cancer&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-016-3889-6&volume=158&issue=3&pages=485-95&publication_year=2016&author=Nahleh%2CZA&author=Barlow%2CWE&author=Hayes%2CDF&author=Schott%2CAF&author=Gralow%2CJR&author=Sikov%2CWM&author=Perez%2CEA&author=Chennuru%2CS&author=Mirshahidi%2CHR&author=Corso%2CSW?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19381954
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Quantitative%2C%20fluorescence-based%20in-situ%20assessment%20of%20protein%20expression&journal=Methods%20Mol%20Biol&doi=10.1007%2F978-1-60327-811-9_12&volume=520&pages=163-75&publication_year=2009&author=Moeder%2CCB&author=Giltnane%2CJM&author=Moulis%2CSP&author=Rimm%2CDL?
- What are the earnings of https://doi.org/10.1038%2Fnm791?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12389040?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Automated%20subcellular%20localization%20and%20quantification%20of%20protein%20expression%20in%20tissue%20microarrays&journal=Nat%20Med&doi=10.1038%2Fnm791&volume=8&issue=11&pages=1323-7&publication_year=2002&author=Camp%2CRL&author=Chung%2CGG&author=Rimm%2CDL?
- What's the income generated by https://doi.org/10.1158%2F1078-0432.CCR-15-0757 each month?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26423797 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Subtype-specific%20metagene-based%20prediction%20of%20outcome%20after%20neoadjuvant%20and%20adjuvant%20treatment%20in%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-15-0757&volume=22&issue=2&pages=337-45&publication_year=2016&author=Callari%2CM&author=Cappelletti%2CV&author=D%E2%80%99Aiuto%2CF&author=Musella%2CV&author=Lembo%2CA&author=Petel%2CF&author=Karn%2CT&author=Iwamoto%2CT&author=Provero%2CP&author=Daidone%2CMG earn?
- How much does https://doi.org/10.1093%2Fannonc%2Fmdv571 gross monthly?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26598540 is on a monthly basis
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Clinical%20validity%20of%20tumor-infiltrating%20lymphocytes%20analysis%20in%20patients%20with%20triple-negative%20breast%20cancer&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdv571&volume=27&issue=2&pages=249-56&publication_year=2016&author=Pruneri%2CG&author=Vingiani%2CA&author=Bagnardi%2CV&author=Rotmensz%2CN&author=Rose%2CA&author=Palazzo%2CA&author=Colleoni%2CAM&author=Goldhirsch%2CA&author=Viale%2CG produce monthly?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26387142?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Immune%20modulation%20of%20pathologic%20complete%20response%20after%20neoadjuvant%20HER2-directed%20therapies%20in%20the%20NeoSphere%20trial&journal=Ann%20Oncol&volume=26&issue=12&pages=2429-36&publication_year=2015&author=Bianchini%2CG&author=Pusztai%2CL&author=Pienkowski%2CT&author=Im%2CYH&author=Bianchi%2CGV&author=Tseng%2CLM&author=Liu%2CMC&author=Lluch%2CA&author=Galeota%2CE&author=Magazzu%2CD each month?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Effects%20of%20neoadjuvant%20chemotherapy%20%28NAC%29%20on%20tumor%20infiltrating%20lymphocytes%20%28TIL%29%20and%20PD-L1%20expression%20in%20the%20SWOG%20S0800%20clinical%20trial&journal=J%20Clin%20Oncol.&volume=35&issue=Suppl&publication_year=2017&author=Pelekanou%2CV&author=Barlow%2CWE&author=Wahlde%2CM-C&author=Wasserman%2CB&author=Lo%2CY-C&author=Hayes%2CDF&author=Hortobagyi%2CGN&author=Gralow%2CJ&author=Tripathy%2CD&author=Livingston%2CRL?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Tumor%20infiltrating%20lymphocytes%20before%20and%20after%20dual%20HER2%20blockade%20in%20HER2-amplified%20early%20breast%20cancer%3A%20a%20TRYPHAENA%20substudy&journal=J%20Clin%20Oncol.&volume=34&issue=Suppl&publication_year=2016&author=Ignatiadis%2CM&author=Eynden%2CGG&author=Salgado%2CR&author=Fornili%2CM&author=Desmedt%2CC&author=Holgado%2CE&author=McNally%2CVA&author=Kiermaier%2CAC&author=Cortes%2CJ&author=Schneeweiss%2CA?
- Revenue of https://doi.org/10.1016%2Fj.molimm.2007.08.013
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17920123
- How much does http://scholar.google.com/scholar_lookup?&title=Chemopreventive%20agents%20induce%20programmed%20death-1-ligand%201%20%28PD-L1%29%20surface%20expression%20in%20breast%20cancer%20cells%20and%20promote%20PD-L1-mediated%20T%20cell%20apoptosis&journal=Mol%20Immunol&doi=10.1016%2Fj.molimm.2007.08.013&volume=45&issue=5&pages=1470-6&publication_year=2008&author=Zhang%2CP&author=Su%2CDM&author=Liang%2CM&author=Fu%2CJ pull in monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20plus%20standard%20neoadjuvant%20therapy%20for%20high-risk%20breast%20cancer%20%28BC%29%3A%20Results%20from%20I-SPY%202&journal=J%20Clin%20Oncology.&volume=35&issue=Suppl&publication_year=2017&author=Nanda%2CR&author=Liu%2CMC&author=Yau%2CC&author=Asare%2CS&author=Hylton%2CN&author=Van%E2%80%99t%20Veer%2CL&author=Perlmutter%2CJ&author=Wallace%2CAM&author=Chien%2CAJ&author=Forero-Torres%2CA make?
- What's the financial outcome of https://doi.org/10.1001/jamaoncol.2017.0013?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27473061 generate?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966732?
- How much does http://scholar.google.com/scholar_lookup?&title=Quantitative%20assessment%20of%20the%20spatial%20heterogeneity%20of%20tumor-infiltrating%20lymphocytes%20in%20breast%20cancer&journal=Breast%20Cancer%20Res&doi=10.1186%2Fs13058-016-0737-x&volume=18&issue=1&publication_year=2016&author=Mani%2CNL&author=Schalper%2CKA&author=Hatzis%2CC&author=Saglam%2CO&author=Tavassoli%2CF&author=Butler%2CM&author=Chagpar%2CAB&author=Pusztai%2CL&author=Rimm%2CDL bring in each month?
- What are the total earnings of https://doi.org/10.1001/jamaoncol.2016.3015?
- How profitable is https://citation-needed.springer.com/v2/references/10.1186/s13058-017-0884-8?format=refman&flavour=references?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vasiliki%20Pelekanou?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vasiliki%20Pelekanou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Daniel%20E.%20Carvajal-Hausdorf?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Daniel%20E.%20Carvajal-Hausdorf%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mehmet%20Altan's earnings
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mehmet%20Altan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Brad%20Wasserman
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Brad%20Wasserman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cristobal%20Carvajal-Hausdorf?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cristobal%20Carvajal-Hausdorf%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hallie%20Wimberly?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hallie%20Wimberly%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jason%20Brown generate monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jason%20Brown%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Donald%20Lannin
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Donald%20Lannin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lajos%20Pusztai
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lajos%20Pusztai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=David%20L.%20Rimm generate?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22David%20L.%20Rimm%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much does https://doi.org/10.1186/s13058-017-0898-2 rake in every month?
- See how much https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_MOESM1_ESM.xlsx makes per month
- Get to know https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_MOESM2_ESM.tif's earnings
- Get to know https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_MOESM3_ESM.docx's earnings
- Check the income stats for https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_MOESM4_ESM.tif
- What's the financial intake of https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-017-0884-8/MediaObjects/13058_2017_884_MOESM5_ESM.tif?
- How much does http://creativecommons.org/licenses/by/4.0/ rake in every month?
- How much does http://creativecommons.org/publicdomain/zero/1.0/ pull in?
- How much does https://s100.copyright.com/AppDispatchServlet?title=Effect%20of%20neoadjuvant%20chemotherapy%20on%20tumor-infiltrating%20lymphocytes%20and%20PD-L1%20expression%20in%20breast%20cancer%20and%20its%20clinical%20significance&author=Vasiliki%20Pelekanou%20et%20al&contentID=10.1186%2Fs13058-017-0884-8©right=The%20Author%28s%29.&publication=1465-542X&publicationDate=2017-08-07&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 gross monthly?
- What's the financial intake of https://crossmark.crossref.org/dialog/?doi=10.1186/s13058-017-0884-8?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1186/s13058-017-0884-8?format=refman&flavour=citation bring in?
- What's the revenue for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- Financial intake of https://www.springernature.com/gp/products
- What's the income of https://www.springernature.com/gp/librarians?
- How much money does https://www.springernature.com/gp/societies generate?
- Earnings of https://www.springernature.com/gp/partners
- How much money does https://www.springer.com/ make?
- How much does https://www.nature.com/ pull in?
- How much profit does https://www.biomedcentral.com/ make?
- How much revenue does https://www.palgrave.com/ produce monthly?
- What is the earnings of https://www.apress.com/?
- How much does https://www.springernature.com/gp/legal/ccpa make?
- How much cash flow does https://www.springernature.com/gp/info/accessibility have monthly?
- How much does https://support.springernature.com/en/support/home rake in every month?
- How much revenue does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations produce monthly?
- https://www.springernature.com/'s revenue stream
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref